{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:14:43Z","timestamp":1760188483736},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.jdermsci.2005.01.005","type":"journal-article","created":{"date-parts":[[2005,2,17]],"date-time":"2005-02-17T23:09:22Z","timestamp":1108681762000},"page":"189-195","source":"Crossref","is-referenced-by-count":16,"title":["Treatment with IFN-\u03b3 increases serum levels of Th1 chemokines and decreases those of Th2 chemokines in patients with mycosis fungoides"],"prefix":"10.1016","volume":"38","author":[{"given":"Ryosuke","family":"Hino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatoshi","family":"Shimauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Tokura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2005.01.005_bib1","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jdermsci.2005.01.005_bib2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/1523-1747.ep12398454","article-title":"Th2 cytokine mRNA expression in skin in cutaneous T cell lymphoma","volume":"103","author":"Vowels","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2005.01.005_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2559.1992.tb00343.x","article-title":"Differential expression of the HECA-452 antigen (cutaneous lymphocyte-associated antigen, CLA) in cutaneous and non-cutaneous T-cell lymphomas","volume":"21","author":"Noorduyn","year":"1992","journal-title":"Histopathology"},{"key":"10.1016\/j.jdermsci.2005.01.005_bib4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/1523-1747.ep12363378","article-title":"The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens","volume":"107","author":"Berger","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2005.01.005_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2249.1998.00599.x","article-title":"Tumour-specific cytotoxic T lymphocyte activity in Th2-type S\u00e9zary syndrome: its enhancement by interferon-\u03b3 (IFN-\u03b3) and IL-12 and fluctuations in association with disease activity","volume":"112","author":"Seo","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jdermsci.2005.01.005_bib6","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2336\/nishinihonhifu.51.766","article-title":"Phase II study of recombinant human interferon \u03b3 (SUN4800) for cutaneous malignancies","volume":"51","author":"Ishihara","year":"1989","journal-title":"Nishinihon Hifuka"},{"key":"10.1016\/j.jdermsci.2005.01.005_bib7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/jnci\/82.3.208","article-title":"Phase II study of recombinant human interferon \u03b3 for treatment of cutaneous T-cell lymphoma","volume":"82","author":"Kaplan","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jdermsci.2005.01.005_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.immunol.18.1.217","article-title":"The biology of chemokines and their receptors","volume":"18","author":"Rossi","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jdermsci.2005.01.005_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cellimm.2004.03.011","article-title":"Roxithromycin downmodulates Th2 chemokine production by keratinocytes and chemokine receptor expression on Th2 cells: its dual inhibitory effects on the ligands and the receptors","volume":"228","author":"Kobayashi","year":"2004","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jdermsci.2005.01.005_bib10","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.187.6.875","article-title":"Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes","volume":"187","author":"Sallusto","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.jdermsci.2005.01.005_bib11","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1046\/j.1523-1747.2002.19610.x","article-title":"Increased CCR4 expression in cutaneous T cell lymphoma","volume":"19","author":"Ferenczi","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2005.01.005_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mjd.2003.132","article-title":"Thymus and activation-regulated chemokine (TARC\/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides","volume":"48","author":"Kakinuma","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdermsci.2005.01.005_bib13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1365-2133.2003.05224.x","article-title":"The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and S\u00e9zary syndrome","volume":"148","author":"Papadavid","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdermsci.2005.01.005_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00000372-197900110-00002","article-title":"The patch stage of mycosis fungoides","volume":"1","author":"Sanches","year":"1979","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jdermsci.2005.01.005_bib15","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00000478-199407000-00001","article-title":"The histollogic spectrum of mycosis fungoides\/S\u00e9zary syndrome (cutaneous T-cell lymphoma). A review of 222 biopsies, including newly described patterns and the earliest pathologic changes","volume":"18","author":"Shapiro","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jdermsci.2005.01.005_bib16","doi-asserted-by":"crossref","first-page":"7701","DOI":"10.1073\/pnas.82.22.7701","article-title":"Low frequency of somatic mutation in beta-chain variable region genes of human T-cell receptors","volume":"82","author":"Ikuta","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jdermsci.2005.01.005_bib17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0190-9622(07)80011-9","article-title":"CD7-positive S\u00e9zary syndrome with a Th1 cytokine profile","volume":"34","author":"Yagi","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdermsci.2005.01.005_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0923-1811(02)00138-X","article-title":"Lack of evidence for TARC\/CCL17 production by normal human keratinocytes in vitro","volume":"31","author":"Tsuda","year":"2003","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jdermsci.2005.01.005_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/cyto.2002.1965","article-title":"IL-4, but not IL-13, modulates TARC (thymus and activation-regulated chemokine)\/CCL17 and IP-10 (interferon-induced protein of 10kDA)\/CXCL10 release by TNF-\u03b1 and IFN-\u03b3 in HaCaT cell line","volume":"20","author":"Kakinuma","year":"2002","journal-title":"Cytokine"},{"key":"10.1016\/j.jdermsci.2005.01.005_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0923-1811(02)00149-4","article-title":"Both IL-4 and IL-13 inhibit the TNF-alpha and IFN-gamma enhanced MDC production in a human keratinocyte cell line, HaCaT cells","volume":"31","author":"Xiao","year":"2003","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jdermsci.2005.01.005_bib21","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.1074\/jbc.M005773200","article-title":"Transcription of the interferon \u03b3 (IFN-\u03b3)-inducible chemokine Mig in IFN-\u03b3-deficient mice","volume":"276","author":"Mahalingam","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jdermsci.2005.01.005_bib22","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1365-2133.2004.05937.x","article-title":"Tumour necrosis factor-\u03b1 but not interferon-\u03b3 is the main inducer of inducible protein-10 in skin fibroblasts from patients with atopic dermatitis","volume":"150","author":"Villagomez","year":"2004","journal-title":"Br J Dermatol"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181105000265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181105000265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T15:28:30Z","timestamp":1548689310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181105000265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0923181105000265"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2005.01.005","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}